Medifron DBT Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

16.21%

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Seong Jun Shin

Internal Auditor

Co-Chief Executive Officer, Director · since 2012

Gi Seon Noh

Co-Chief Executive Officer, Director · since 2019

Dong Beom Yim

Director · since 2010

Jong Mo Kim

Non-Executive Independent Director · since 2012

URL

IPO date

Jan 21, 2003

Employees

Domiciled in

Incorporated in

No data to show